title: Commercialization of a novel fermentation concept.
abstract: Fermentation is the core of biotechnology where current methodologies span across technologies based on the use of either solid or liquid substrates. Traditionally, solid substrate fermentation technologies have been the widely practiced in the Far East to manufacture fermented foods such as soya sauce, sake etc. The Western World briefly used solid substrate fermentation for the manufacture of antibiotics and enzymes but rapidly replaced this technology with submerged fermentation which proved to be a superior technology in terms of automation, containment and large volume fermentation. Biocon India developed its enzyme technology based on solid substrate fermentation as a low-cost, low-energy option for the production of specialty enzymes. However, the limitations of applying solid substrate fermentation to more sophisticated biotechnology products as well as large volume fermentations were recognized by Biocon India as early as 1990 and the company embarked on a 8 year research and development program to develop a novel bioreactor capable of conducting solid substrate fermentation with comparable levels of automation and containment as those practiced by submerged fermentation. In addition, the novel technology enabled fed-batch fermentation, in situ extraction and other enabling features that will be discussed in this article. The novel bioreactor was christened the "PlaFractor" (pronounced play-fractor). The next level of research on this novel technology is now focused on addressing large volume fermentation. This article traces the evolution of Biocon India's original solid substrate fermentation to the PlaFractor technology and provides details of the scale-up and commercialization processes that were involved therein. What is also apparent in the article is Biocon India's commercially focused research programs and the perceived need to be globally competitive through low costs of innovation that address, at all times, processes and technologies that exhibit high degrees of conformance to the international standards of regulatory and good manufacturing practice.
authors.affiliation: Biocon India Limited, 20th Km, Hosur Road, Hebbagodi 561229, Bangalore, India. Kiran.Mazumdar@bioconindia.com
authors.forename: Kiran
authors.initials: K
authors.lastname: Mazumdar-Shaw
authors.forename: Shrikumar
authors.initials: S
authors.lastname: Suryanarayan
mesh_terms: D019149:Bioreactors; D001709:Biotechnology / Q000191:economics / Q000295:instrumentation* / Q000379:methods*; D004798:Enzymes / Q000096:biosynthesis* / Q000302:isolation & purification; D004867:Equipment Design; D005285:Fermentation; D007218:Industrial Microbiology / Q000191:economics / Q000295:instrumentation* / Q000379:methods; D004364:Pharmaceutical Preparations / Q000138:chemical synthesis / Q000378:metabolism*
chemical_list: D004798:Enzymes; D004364:Pharmaceutical Preparations